Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion type Assertion NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_head.
- NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion description "[Our results indicate that SNPs in the NER genes ERCC1 (Asn118Asn, 15310G>C, 8902G>T), XPA (-4G>A), ERCC2/XPD (Lys751Gln) and ERCC5/XPD (His46His); the BER genes APE1/APEX (Ile64Val), OGG1 (Ser326Cys), PCNA (1876A>G) and XRCC1 (Arg194Trp, Arg280His, Arg399Gln); and the DSB-R genes ATR (Thr211Met), NBS1 (Glu185Gln), XRCC2 (Arg188His) and XRCC9 (Thr297Ile) modulate NSCLC risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_provenance.
- NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion evidence source_evidence_literature NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_provenance.
- NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion SIO_000772 16195237 NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_provenance.
- NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion wasDerivedFrom befree-2016 NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_provenance.
- NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_assertion wasGeneratedBy ECO_0000203 NP515738.RATphrb5u6sNY5M0TOFgnVJGRWsI-Rl62x_CH-S6EQj88130_provenance.